Categories
Dr. Lal Path Labs Ltd. — Board Meeting, 30-04-2026: Outcome of Board Meeting
30-04-2026 · 03:21 pm
Dr. Lal PathLabs' board approved FY26 consolidated results: Revenue at ₹2,762.9 Cr, Profit at ₹509.8 Cr. The board proposed a ₹4/share final dividend. Key decisions also include acquiring Shahbazkers Diagnostic Centre for up to ₹20 Cr and establishing a new WOS in Dubai for global expansion.
No comments yet. Be the first to comment!